Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin.
暂无分享,去创建一个
M. Morgan | C. Drescher | D. Dizon | D. Armstrong | M. Seiden | H. Lee | C. Krasner | J. Wolfe | U. Matulonis | C. Castro | M. Birrer | M. Roche | J. Supko | R. Penson